Characterization of the enzymatic activity of PSM: Comparison with brain NAALADase

Prostate

Volumn 39, Issue 1, 1999, Pages 28-35

  Tiffany, Carol W ^a   Lapidus, Rena G ^a   Merion, Aviva ^a   Calvin, David C ^a   Slusher, Barbara S ^a  

^a GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

Dunning; Folic acid; LNCAP; Prostate cancer

Indexed keywords

DIPEPTIDASE; HYDROLASE; PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CATALYSIS; CYTOSOL; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; HYDROLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; BRAIN; CARBOXYPEPTIDASES; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; KINETICS; MALE; PROSTATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED;

EID: 0033560036     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990401)39:1<28::AID-PROS5>3.0.CO;2-A     Document Type: Article

References (22)

1. Carter RF, Feldman AR, Coyle JT. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci USA 1996; 93:749-753.
2. Heston WDW. Characterization and glutamyl preferring carboxypeptidase function of prostate-specific membrane antigen: a novel folate hydrolase. Urology [Suppl]1997;49:104-112.
3. Fair WR, Israeli RS, Heston WDW. Prostate-specific membrane antigen. Prostate 1997;32:140-148.
4. Israeli RS, Powell CT, Fair WR, Heston WDW. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 1993;53:227-230.
5. Su SL, Huang IP, Fair WR, Powell CT, Heston WDW. Alternatively spliced variants of prostate-specific membrane antigen RNA; ratio of expression as potential measure of progress. Cancer Res 1995;55:1441-1443.
6. Kawakami M, Nakayama J. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer a revealed by in situ hybridization. Cancer Res 1997;57:2321-2324.
7. Loric S, Dumas F, Eschwege P, Blanchet P, Benoit G, Jardin A, Lacour B. Enhanced detection of hematogenous circulating prostate cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clin Chem 1995; 41:1698-1704.
8. Rochon YP, Horoszewicz JS, Boynton AL, Holmes EH, Barron RJ III, Erickson SJ, Kenny GM, Murphy GP. Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients. Prostate 1994;25:219-223.
9. Slusher BS, Robinson MB, Tsai G, Simmons ML, Richards SS, Coyle JT. Rat brain N-acetylated alpha-linked acidic dipeptidase activity. J Biol Chem 1990;265:21297-21301.
10. Robinson MB, Blakely RD, Couto R, Coyle JT. Hydrolysis of the brain dipeptide N-acetyl-aspartyl-L-glutamate. J Biol Chem 1987;262:14498-14506.
11. Slusher BS, Tsai G, Yoo G, Coyle JT. Immunocytochemical localization of the N-acetyl-aspartyl-glutamate hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase [NAALADase]. J Comp Neurol 1992;315:217-229.
12. Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 1994;17:31-108.
13. Stauch BL, Robinson MB, Forloni G, Tsai G, Coyle JT. The effects of N-acetylated alpha-linked acidic dipeptidase [NAALADase] inhibitors on [3H]NAAG catabolism in vivo. Neurosci Lett 1989; 100:295-300.
14. Pinto JT, Suffoletto BP, Berzin TM, Qiao CH, Lin S, Tong WP, May F, Mukherjee B, Heston WDW. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res 1996;2:1445-1451.
15. Hoehn W, Schroeder FH, Riemann JF, Joebsis AC, Hermanek P. Human prostatic adenocarcinoma: some characteristics of a serially transplantable line in nude mice (PC-82). Prostate 1980;1: 95-104.
16. Jackson PF, Cole DK, Slusher BS, Stetz SL, Ross LE, Donzanti BA, Trainor DA. Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated α-linked acidic dipeptidase. J Med Chem 1996;39:619-622.
17. Silver DA, Pellicer I, Fair WR, Heston WDW, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant tissues. Clin Cancer Res 1997;3:81-85.
18. Holmes EH, Greene TG, Tino WT, Boynton AL, Aldape HC, Misrock SL, Murphy GP. Analysis of glycosylation of prostate specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients. Prostate [Suppl] 1996;7:25-29.
19. Heston WDW, Silver DA, Pellicer I, Fair WR, Cordon-Cardo C. lonotrophic glutamate receptor distribution in prostate tissue. J Urol 1996;155:513.
20. Corvol P, Michaud A, Soubrier F, Williams TA. Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme. J Hypertens 1995;13:53-60.
21. Krongrad A, Atochina E, Ryan JW, Roos BA. Endopeptidase 24.11 activity in the human prostate cancer cell lines LNCaP and PPC-1. Urol Res 1997;25:113-116.
22. Papandreou CN, Usmani B, Geng Y, Bogenreider T, Freeman R, Wilk S, Finstad CL, Reuter VE, Powell CT, Scheinberg D, Magill C, Scher HI, Albino AP, Nanus DM. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med 1998;4:50-57.